Bank of America’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q2 | – | Sell |
-2,746
| Closed | -$268K | – | 6378 |
|
|
2015
Q1 | $268K | Sell |
2,746
-62
| -2% | -$6.05K | ﹤0.01% | 3854 |
|
|
2014
Q4 | $261K | Sell |
2,808
-153
| -5% | -$14.2K | ﹤0.01% | 4001 |
|
|
2014
Q3 | $204K | Buy |
2,961
+2,226
| +303% | +$153K | ﹤0.01% | 4050 |
|
|
2014
Q2 | $77K | Sell |
735
-4,944
| -87% | -$518K | ﹤0.01% | 4769 |
|
|
2014
Q1 | $471K | Buy |
5,679
+4,492
| +378% | +$373K | ﹤0.01% | 3580 |
|
|
2013
Q4 | $77K | Buy |
1,187
+428
| +56% | +$27.8K | ﹤0.01% | 4681 |
|
|
2013
Q3 | $48K | Sell |
759
-10,704
| -93% | -$677K | ﹤0.01% | 4742 |
|
|
2013
Q2 | $481K | Buy |
+11,463
| New | +$481K | ﹤0.01% | 3746 |
|